Nilsine Partners LLC Sells 7,507 Shares of Intuitive Surgical, Inc. $ISRG

Nilsine Partners LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 51.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,986 shares of the medical equipment provider’s stock after selling 7,507 shares during the quarter. Nilsine Partners LLC’s holdings in Intuitive Surgical were worth $3,124,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of ISRG. Tobam increased its stake in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the period. Kilter Group LLC bought a new stake in Intuitive Surgical in the 2nd quarter worth $27,000. Princeton Global Asset Management LLC purchased a new position in shares of Intuitive Surgical in the second quarter valued at about $30,000. TD Capital Management LLC raised its stake in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new position in shares of Intuitive Surgical during the first quarter valued at about $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the sale, the executive vice president directly owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. This represents a 81.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 7,562 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at $193,595.79. This trade represents a 95.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 114,007 shares of company stock worth $63,533,844 over the last quarter. 0.70% of the stock is owned by insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $559.52 on Tuesday. The firm has a market capitalization of $200.58 billion, a P/E ratio of 74.01, a PEG ratio of 4.98 and a beta of 1.68. The company’s 50-day simple moving average is $531.81 and its 200 day simple moving average is $505.39. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the previous year, the business earned $1.84 earnings per share. The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Daiwa Capital Markets boosted their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Rothschild & Co Redburn boosted their target price on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a research note on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Finally, Evercore ISI upped their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $608.79.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.